LOS ANGELES, March 01, 2017 -- Apollo Enterprise Solutions, Ltd. (OAL:DE; AES:BH), an Application Software Technology company, announced at the Monaco Growth Forum’s Wealth Management Conference in Dubai, the worldwide launch of its breakthrough TrueWealthManager™ System.
Powered by AES’s patented Psychographic Conversion™ technology, and integrated with the Oracle Wealth Management System, TrueWealthManager™ will increase the ability of Wealth Managers, Family Offices, and Private Bankers to originate and retain High Net Worth Investor clients.
Joseph Konowiecki, the Chairman and CEO of AES commented, “Our TrueWealthManager™ product provides an advantage for small and medium size Asset Managers who, by using our patented Psychographic Conversion™ technologies, should attract many more investors and will make many more informed decisions, while maintaining high quality, impactful communication throughout the working relationship.
“The Asset Management sector is undergoing a tectonic shift, with clients demanding highly personalized services and a 360-degree view of investment opportunities. Nowhere is this more apparent than in the EU, GCC and Far East, where traditional financial services have given way to bespoke family offices and private asset management boutiques. Supported by Oracle’s global network, AES will be able to deliver its TrueWealthManager™ product affordably, virtually anywhere in the world.”
AES plans to implement its TrueWealthManager™ System in Q2 and will lead the international effort out of its Canary Wharf Financial District office in London.
Apollo Enterprise Solutions, Ltd. is publicly traded on the German Xetra Exchange under the symbol “OAL”
http://en.boerse-frankfurt.de/stock/Apollo_Enterprise_Solutions-share/ETR
About Apollo Enterprise Solutions, LTD
AES’ TrueConversion™ suite of products, powered by Psychographic Conversion™ Application Software Technology, enables healthcare organizations, banks, utilities, merchandisers, and other enterprises to enhance the member, customer and client experience while increasing conversion rates for enrollment, services, and payments. Psychographic Conversion™ uses advanced behavioral psychology, linguistics and artificial intelligence to persuade consumers to take immediate action, at any time, from anywhere using any smart device. The TrueConversion™ suite of products is available on all continents through third-party Certified Systems Integrators and Consultants, supported by AES offices in Los Angeles, New York, London, and Milan. AES owns one of the largest worldwide portfolios of customer conversion patents. More information about Apollo Enterprise Solutions, Ltd. (AES:BH; OAL:GR) is available at www.aestrue.com
Contact: LuAnne Woodbridge, CFO Phone: +001 (562) 513-3709 Email: [email protected]


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



